Nuwellis Inc [NUWE] stock prices are up 1.83% to $0.61 at the moment. Until recently, the best way to gauge how the stock has performed was to look at its short-term value. The NUWE shares have gain 14.74% over the last week, with a monthly amount glided 12.52%, and seem to be holding up well over a long-time horizon.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
On 22, February 2024, Nuwellis’ Distribution Partner, SeaStar Medical, Receives FDA Humanitarian Device Exemption for Pediatric Selective Cytopheretic Device Quelimmune™. In a post published today on Yahoo Finance, Nuwellis, Inc. (Nasdaq: NUWE), a medical technology company focused on transforming the lives of people with fluid overload, today announced its distribution partner, SeaStar Medical Holding Corporation (Nasdaq: ICU) (SeaStar Medical), has received Humanitarian Device Exemption (HDE) from the U.S. Food and Drug Administration (FDA) for Quelimmune™, its pediatric Selective Cytopheretic Device. Quelimmune provides a new therapy option for children weighing 10 kg or more who have acute kidney injury (AKI) and sepsis or a septic condition requiring continuous kidney replacement therapy (CKRT) in a hospital intensive care unit.
From an analyst’s perspective:
The stock price of Nuwellis Inc [NUWE] has been fluctuating between $0.39 and $8.48 over the past year. Nuwellis Inc [NASDAQ: NUWE] shares were valued at $0.61 at the most recent close of the market.
Analyzing the NUWE fundamentals
The Nuwellis Inc [NASDAQ:NUWE] reported sales of 8.65M for trailing twelve months, representing a surge of 16.80%. Gross Profit Margin for this corporation currently stands at -0.03% with Operating Profit Margin at -0.22%, Pretax Profit Margin comes in at -0.24%, and Net Profit Margin reading is -0.51%. To continue investigating profitability, this company’s Return on Assets is posted at -1.53, Equity is -2.61 and Total Capital is -22.65. Upon thorough examination of the company’s fundamental financial framework, it becomes apparent that the debt-to-equity ratio stands at -6.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 0.5247 points at the first support level, and at 0.4383 for the second support level. However, for the 1st resistance point, the stock is sitting at 0.6737, and for the 2nd resistance point, it is at 0.7363.
Nuwellis Inc [NUWE] reported earnings per share of -$1.81 for its fiscal quarter that ended on 9/29/2023. Based on the Wall Street analysts’ estimates, the company was expected to report earnings of -$3.11/share, meaning a difference of $1.3 and a surprise factor of 41.80%. By comparison, the stated earnings for the previous quarter ended on 6/29/2023 were -$3.65 per share as compared to estimates of -$4.02 per share, a difference of $0.37 representing a surprise of 9.20%.
Ratios To Look Out For
It’s worth pointing out that Nuwellis Inc [NASDAQ:NUWE]’s Current Ratio is 3.22. As well, the Quick Ratio is 2.44, while the Cash Ratio is 0.05. Considering the valuation of this stock, the price to sales ratio is 0.40, the price to book ratio is 0.15.
Transactions by insiders
Recent insider trading involved Jaramillo Nestor Jr., President and CEO, that happened on Mar 15 when 4098.0 shares were purchased.
